ArticleHeliyon2025
Walking Economy after an Arm-ergometry versus a Treadmill Supervised Exercise program in patients with Peripheral Artery Disease: Findings from the ARMEX trial.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peripheral artery disease (PAD) significantly affects patient prognosis, leading to a rapid decline in physical function and health-related quality of life. PAD impacts walking economy, causing higher oxygen uptake during submaximal walking, which is crucial for evaluating walking performance and aerobic endurance. Research question: How do arm-ergometry supervised exercise training (AEx) and treadmill exercise training (TEx) compare in their effects on walking economy, and what clinical characteristics and outcomes influence the degree of this improvement? Methods: This study is an ancillary investigation of the ARMEX trial, a single-center, single-blinded, parallel groups, noninferiority randomized clinical trial. Patients with symptomatic PAD were randomized (1:1 ratio) either to a 12-week AEx or TEx. Walking economy was measured by oxygen uptake (V̇O Results: Fifty-six patients (66 ± 8.4 years; 87.5 % male) were enrolled and randomized: AEx (n = 28) and TEx (n = 28). At 12-weeks, V̇O Significance: Treadmill exercise improved walking economy more than arm-ergometry in patients with PAD. Individuals with a higher BMI experience less improvement in walking economy with exercise training and might require specialized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.